7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Prof. İlim Irmak, MD Pulmonary Medicine · Acibadem Atasehir Hospital, İstanbul

Prof. İlim Irmak, MD

✓ Medically verified profile
Pulmonary Medicine · Acibadem Atasehir Hospital, İstanbul

Prof. İlim Irmak, MD

Prof. İlim Irmak, MD is a Pulmonary Medicine specialist in the Pulmonology unit at Acibadem Atasehir Hospital in İstanbul. Her work covers lung cancer and other thoracic cancers, lung nodules, bronchoscopy and EBUS, asthma, chronic obstructive pulmonary disease, pulmonary embolism, sleep apnea, insomnia and lower respiratory tract infections. She consults in Turkish and English.

Medically verified profile 18+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Irmak → Consultation options Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. İlim Irmak, MDAccepting international patients
SpecialtyPulmonary Medicine
DepartmentPulmonology
ConsultationVideo · In person · Second opinion
Profile

About Prof. İlim Irmak, MD

Prof. İlim Irmak, MD is a Pulmonary Medicine specialist working in the Pulmonology unit at Acibadem Atasehir Hospital in İstanbul. She has more than 18 years of experience in medicine. Her clinical work covers lung cancer and other thoracic cancers, lung nodules, bronchoscopy and EBUS, asthma, chronic obstructive pulmonary disease, pulmonary embolism, sleep disorders including insomnia and sleep apnea, and lower respiratory tract infections such as bronchitis and pneumonia.

Dr. Irmak graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 2008 and completed her specialty training in chest diseases at Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital in 2013. From 2019 to 2021 she was a lecturer at Hacettepe University Faculty of Medicine Department of Chest Diseases, and in 2021 she received the title of Associate Professor. She joined Acıbadem Healthcare Services in 2024. She is a member of the European Respiratory Society, the Turkish Respiratory Research Association and the Türk Toraks Association. She has co-authored peer-reviewed publications on topics including cystic fibrosis registry data, COVID-19 pneumonia, the neutrophil-to-lymphocyte ratio as a prognostic marker in small cell lung cancer, and bone mineral density in lung transplant recipients.

Clinical focus

A central part of Dr. Irmak’s practice is the evaluation of lung nodules and the diagnostic work-up of lung cancer and other thoracic cancers. She performs bronchoscopy and EBUS (endobronchial ultrasound), procedures that allow tissue and lymph node sampling from the airways and are used to clarify the nature of suspicious findings on chest imaging. Findings from these procedures are reviewed with the patient and, where relevant, with colleagues from other disciplines so that further steps can be planned.

Dr. Irmak also manages chronic airway conditions such as asthma and chronic obstructive pulmonary disease, as well as acute problems including pulmonary embolism and lower respiratory tract infections such as bronchitis and pneumonia. Her work in sleep medicine covers sleep disorders including insomnia and sleep apnea. Care planning in these areas takes into account the patient’s history, symptoms, lung function and any previous treatment, and is adjusted over time as the clinical picture develops.

How Dr. Irmak works with international patients

Dr. Irmak consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as CT or X-ray reports, laboratory and pathology results, operative notes and discharge summaries, and arranges the appointment and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the available options. Video consultation is available for international patients who wish to discuss their situation with Dr. Irmak before or instead of traveling.

Clinical focus

What Dr. Irmak treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Background

Education, career and memberships

Education & training

Education

  • 2021Associate Professorlk
  • 2013Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital Chest Diseases
  • 2008İstanbul University Cerrahpaşa Faculty of Medicine
Career

Professional Experience

  • 2024Acıbadem Healthcare Services
  • 2019–2021Hacettepe University Faculty of Medicine Department of Chest Diseases / Lecturer
Memberships

Professional Memberships

  • European Respiratory Society
  • Turkish Respiratory Research Association
  • Türk Toraks Association
Selected publications

Selected Publications

  • Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?. Pediatric Pulmonology. (SCI-Expanded)-Q2 (2023) Uytun, S., Cinel, G., Eryılmaz Polat, S., Özkan Tabakçı, S., Kiper, N., Yalçın, E., … & Doğru, D
  • A case-control study of the effects of Aspergillus clinical phenotypes on pulmonary functions in patients with cystic fibrosis Pediatric Pulmonology. (SCI-Expanded)-Q2 (2023) Nayir Buyuksahin, H., Dogru, D. E. N. I. Z., Emiralioglu, N., Ademhan Tural, D., Ozsezen, B., Sunman, B., Irmak, I.,… & Kiper, N
  • Bone Mineral Density in Lung Transplant Recipients: Experience of A Referral Lung Transplantation Center Turkish Journal of Internal Medicine, 5(3), 156-162 82 (2023) GÜNEY, P. A., IRMAK, İ., HALİS, A. N., & SARIBAŞ, E.
  • Clinical characteristics of patients requiring lung transplantation referral in national cystic fibrosis registry data. The Turkish journal of pediatrics, 65(2), 257-268. (SCI-Expanded)-Q4 (2023) Onay, Z. R., Eyübo?lu, T. Ş., Aslan, A. T., Gürsoy, T. R., Yalçın, E., Kiper, N., … & Do?ru, D.
  • Post discharge mortality in the first wave of COVID? 19 in Turkey Asian Pacific Journal of Tropical Medicine, 15(11), 479-484. (SCI-Expanded)-Q2 (2022) Fakili, F., Cetinkaya, P. D., Baydar, O., Baris, S. A., Kokturk, N., Kul, S., … & Bayram, H.
  • The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort. Frontiers in medicine, 2587. (SCI-Expanded)-Q2 (2022) Babayigit, C., Kokturk, N., Kul, S., Cetinkaya, P. D., Atis Nayci, S., Argun Baris, S., Irmak, I. … & Bayram, H.
  • ssociation Between Known Close Contact History and Severity of COVID-19 Pneumonia: A Preliminary Evidence Supporting Importance of Filiation Turkish Thoracic Journal, 23(3), 196-202. (2022) Irmak, I., Inam, M. G., Tekin, F., & Damadoglu, E.
  • The success of the Cystic Fibrosis Registry of Turkey for improvement of patient care. Pediatric pulmonology, 57(5), 1245-1252. (SCI-Expanded)-Q2 Asfuroglu, P., Sismanlar Eyuboglu, T., Aslan, A. T., Gursoy, T. R., Emiralioglu, N., Yalcin, E.,I.Irmak … & Dogru, D.
  • Neutrophil-to-lymphocyte Ratio as a Predictor of Prognosis in Patients with Small Cell Lung Cancer: A Retrospective Study Southern Clinics of Istanbul Eurasia, 32(3). (2021) Guney, P. A., Irmak, I., Kasapoglu, U. S., & Arinc, S.
  • Cuban Blue Scorpion Venom and Lung Carcinoma: Is it Always True What Does Not Kill Me Makes Me Stronger?. Turk Thorac Journal/ Turk Thorac J 2021; 22(3): 265-266 (2021) Damadoglu, E., Irmak, I., & Kalyoncu, A. F.
Good to Know

Frequently Asked Questions

Which conditions and procedures does Dr. Irmak handle?
Dr. Irmak evaluates and manages lung cancer and other thoracic cancers, lung nodules, asthma, chronic obstructive pulmonary disease, pulmonary embolism, sleep disorders including insomnia and sleep apnea, and lower respiratory tract infections such as bronchitis and pneumonia. She performs diagnostic bronchoscopy and EBUS for sampling airway lesions and mediastinal lymph nodes.
Where does Dr. Irmak practice?
Dr. Irmak works in the Pulmonology unit at Acibadem Atasehir Hospital in İstanbul. She joined Acıbadem Healthcare Services in 2024, after serving as a lecturer at Hacettepe University Faculty of Medicine Department of Chest Diseases from 2019 to 2021.
Which languages does Dr. Irmak speak with patients?
Dr. Irmak consults in Turkish and English. For international patients who speak other languages, the international patient team can arrange an interpreter for consultations and for the hospital visit, so that history, findings and options can be discussed clearly.
What should I send for a case review before a consultation with Dr. Irmak?
It is helpful to provide existing chest imaging with reports, such as CT or X-ray, laboratory and pathology results, lung function tests if available, previous bronchoscopy or biopsy reports, operative notes and discharge summaries, and a list of current medications. The international patient team coordinates collection of these documents.
Can I have a video consultation with Dr. Irmak from abroad?
Yes, video consultation is available for international patients. It can be used to review existing reports and imaging, discuss symptoms and previous treatments, and consider possible next steps. Some diagnostic procedures, such as bronchoscopy or EBUS, can only be performed in person at the hospital.
What is Dr. Irmak's training and professional background?
Dr. Irmak graduated from İstanbul University Cerrahpaşa Faculty of Medicine in 2008 and completed chest diseases training at Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital in 2013. She became an Associate Professor in 2021 and is a member of the European Respiratory Society, the Turkish Respiratory Research Association and the Türk Toraks Association.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

We’re With You at Every Step

How can we help you today?

We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.